L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 2, 2000, Pages 197-200

  Kondratieva, T V ^a   Imyanitov, E N ^b   Togo, A V ^b   Zaitseva, O A ^b   Yatsuk, O S ^b   Romanenko, S M ^b   Bersnev, V P ^a   Hanson, K P ^b  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Glioma; GSTM1; L MYC); Polymorphism

Indexed keywords

ALLELE; ARTICLE; CANCER GRADING; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; GLIOMA; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; ONCOGENE MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; BRAIN NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; GENE FREQUENCY; GENES, MYC; GENOTYPE; GLIOMA; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; LEUKOCYTES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0033941457     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sehgal A.: Molecular changes during the genesis of human gliomas. Semin. Surg. Oncol. 14: 3-12, 1998.
2. Kaye F., Battey J.F., Nau M.M. et al.: Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing. Mol. Cell. Biol. 8: 186-195, 1988.
3. Champeme M.H., Bieche I., Latil A., Hacene, K., Lidereau R.: Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancer. Int. J. Cancer Vol. 50: 6-9, 1992.
4. Chernitsa O.I., Togo A.V., Shutkin V.A., Hanson K.P., Imyanitov E.N.: S allele of L-MYC oncogene is associated with metastatic lung cancer in patients from Moldova. Eur. J. Cancer 34: 1816-1817, 1998.
5. Kato M., Toguchida J., Honda K. et al.: Elevated frequency of a specific allele of the L-myc gene in male patients with bone and soft-tissue sarcomas. Int. J. Cancer 45: 47-49, 1990.
6. Kawashima K., Shikama H., Imoto K. et al.: Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc. Natl. Acad. Sci. USA 85: 2353-2356, 1988.
7. Kawashima K., Nomura S., Hirai H. et al.: Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients. Int. J. Cancer 50: 557-561, 1992.
8. Young J., Buttenshaw R., Butterworth L. et al.: Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene 9: 1053-1056, 1994.
9. d'Ericco A., Taioli E., Chen X., Vineis P.: Genetic metabolic polymorphisms and the risk of cancer: a review of literature. Biomarkers 1: 149-173, 1996.
10. Mullenbach, R., Lagoda, P.J., Welter, C.: An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5: 391, 1989.
11. Togo A.V., Suspitsin E.N., Grigoriev M. Yu. et al.: Study of L-myc polymorphism in cancer patients, healthy donors and elderly tumour-free individuals. Int. J. Cancer (in press).
12. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W.: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85: P. 1159-1164, 1993.
13. Elexpuru-Camiruaga J., Buxton N., Kandula V. et al.: Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res. 55: 4237-4239, 1995.
14. Trizna Z., de Andrade M., Kyritsis A.P. et al.: Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol. Biomarkers Prev. 7: 553-555, 1998.
15. Wiencke J.K., Wrensch M.R., Miike R., Zuo Z., Kelsey K.T.: Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. Carcinogenesis 18: 1431-1433, 1997.
16. Kelsey K.T., Wrensch M., Zuo Z.F., Miike R., Wiencke J.K.: A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics, 7: 463-468, 1997.